 - Except for the following, no other malignancy is allowed: synchronous ipsilateral breast cancer of the same subtype ERPR, HER-2neu, adequately treated basal cell or squamous cell skin cancer, in situcervical cancer or other stage I or II cancer from which the patient has been disease free for at least 5 years 